NO2296686T3 - - Google Patents

Info

Publication number
NO2296686T3
NO2296686T3 NO09751584A NO09751584A NO2296686T3 NO 2296686 T3 NO2296686 T3 NO 2296686T3 NO 09751584 A NO09751584 A NO 09751584A NO 09751584 A NO09751584 A NO 09751584A NO 2296686 T3 NO2296686 T3 NO 2296686T3
Authority
NO
Norway
Application number
NO09751584A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2296686(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2296686T3 publication Critical patent/NO2296686T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO09751584A 2008-05-21 2009-05-21 NO2296686T3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21
PCT/US2009/044860 WO2009143356A1 (fr) 2008-05-21 2009-05-21 Desmopressine orodispersible augmentant la période initiale de sommeil non perturbé par la nycturie

Publications (1)

Publication Number Publication Date
NO2296686T3 true NO2296686T3 (fr) 2014-07-12

Family

ID=41100519

Family Applications (3)

Application Number Title Priority Date Filing Date
NO09751584A NO2296686T3 (fr) 2008-05-21 2009-05-21
NO16165875A NO3085381T3 (fr) 2008-05-21 2009-05-21
NO2019021C NO2019021I1 (no) 2008-05-21 2019-04-30 Desmopressin eller et acetatsalt derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO16165875A NO3085381T3 (fr) 2008-05-21 2009-05-21
NO2019021C NO2019021I1 (no) 2008-05-21 2019-04-30 Desmopressin eller et acetatsalt derav

Country Status (16)

Country Link
US (2) US9974826B2 (fr)
EP (5) EP3225249B1 (fr)
JP (5) JP5767103B2 (fr)
CA (1) CA2724653A1 (fr)
DK (5) DK3085381T3 (fr)
ES (5) ES2677548T3 (fr)
HR (4) HRP20161066T1 (fr)
HU (5) HUE039013T4 (fr)
LT (5) LT2712622T (fr)
LU (1) LUC00015I2 (fr)
NO (3) NO2296686T3 (fr)
PL (5) PL3225250T3 (fr)
PT (5) PT2296686E (fr)
SI (4) SI2712622T1 (fr)
TR (2) TR201807224T4 (fr)
WO (1) WO2009143356A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3085381T3 (en) * 2008-05-21 2018-05-28 Ferring Bv ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2015063602A1 (fr) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressine et glycémie
CA3116290A1 (fr) * 2018-10-17 2020-04-23 Nippon Chemiphar Co., Ltd. Agent therapeutique ou prophylactique pour la nocturie
US20230149330A1 (en) * 2020-04-14 2023-05-18 Nippon Chemiphar Co., Ltd. Sleep quality improver
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
EP0084705B1 (fr) 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Procédé de préparation d'articles façonnés solides
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
TW279133B (fr) 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9101022D0 (sv) * 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
CA2070061C (fr) 1991-06-07 2004-02-10 Shigeyuki Takama Composition pharmaceutique renfermant des polypeptides physiologiquement actives
CA2103163C (fr) 1991-08-26 1998-10-20 Mou-Ying Fu Lu Compositions et methodes pour l'administratiion sublinguale ou buccale d'agents therapeutiques
HU219349B (en) 1991-12-24 2001-03-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation and production thereof
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) * 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (fr) 1993-02-24 1996-05-21 Hema-Quebec Utilisation du paf
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
ES2149880T3 (es) * 1993-06-29 2000-11-16 Ferring Bv Sintesis de peptidos ciclicos.
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
WO1995001183A1 (fr) 1993-06-29 1995-01-12 Ferring B.V. Compositions permettant l'administration par voie nasale de desmopressine
DE69434626D1 (de) * 1993-11-17 2006-04-20 Athena Neurosciences Inc Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
DE19518932C2 (de) * 1994-05-23 1999-03-18 Samsung Electro Mech Vorrichtung zur Perforation der Haut für die Vorbereitung einer transdermalen Medikation
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) * 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
CA2253549C (fr) * 1996-06-18 2005-10-25 Alza Corporation Dispositif d'amelioration d'apport ou d'echantillonnage d'agents transdermiques
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6194407B1 (en) * 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6511974B1 (en) * 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6344451B1 (en) * 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6235900B1 (en) * 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6297234B1 (en) * 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
WO2000047233A1 (fr) 1999-02-15 2000-08-17 Sumitomo Pharmaceuticals Co., Ltd. Comprimes se desintegrant rapidement dans la cavite buccale
JP2002537031A (ja) 1999-02-18 2002-11-05 バイオバルブ テクノロジーズ インコーポレイテッド 電気活性な細孔
AR014640A1 (es) * 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
WO2001051109A1 (fr) 2000-01-07 2001-07-19 Biovalve Technologies, Inc. Dispositif d"injection
US20070032410A1 (en) * 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
TWI287984B (en) * 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
DE60138407D1 (de) 2000-10-26 2009-05-28 Alza Corp Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US20020156418A1 (en) 2000-11-30 2002-10-24 Gonnelli Robert R. Injection systems
ES2705729T3 (es) 2000-11-30 2019-03-26 Valeritas Inc Sistemas de suministro y medición de fluidos
WO2002064193A2 (fr) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Appareils a microaiguilles et fabrication
AU2002231207A1 (en) * 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
IL157822A0 (en) 2001-03-16 2004-03-28 Alza Corp Transdermal patch for administering fentanyl
DE60222879T2 (de) * 2001-04-12 2008-07-24 Wyeth Cyclohexylphenyl vasopressin agonisten
WO2002083145A1 (fr) * 2001-04-12 2002-10-24 Wyeth Azepines et diazepines bi et tricycliques substituees n-biphenylcarbonyle et n-phenylpyridylcarbonyle utilisees en tant qu'agonistes de la vasopressine
US7022699B2 (en) * 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7615234B2 (en) * 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
GB2391480B (en) * 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
MXPA04002449A (es) 2001-09-13 2004-07-23 Kissei Pharmaceutical Cristales de derivado de hidroxinorefedrina.
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
US7169772B2 (en) * 2001-11-16 2007-01-30 Astellas Pharma Inc. 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof
PT1501534E (pt) 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US6945952B2 (en) * 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
US20040115167A1 (en) * 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors
WO2004033457A1 (fr) * 2002-10-09 2004-04-22 Toray Industries, Inc. Remedes ou produits preventifs pour la frequence urinaire ou l'incontinence urinaire, et derives de morphinane presentant un groupe heterocylique contenant de l'azote
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (fr) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Composition pour dissolution rapid d'un composè lipophile
DE10259934B3 (de) * 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
KR100882154B1 (ko) * 2003-04-28 2009-02-06 아스텔라스세이야쿠 가부시키가이샤 4,4-디플루오로-1,2,3,4-테트라하이드로-5ｈ-1-벤즈아제핀 유도체 또는 이의 염 및 이를 포함하는 의약 조성물
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
BRPI0412021A (pt) 2003-06-30 2006-08-15 Alza Corp método para revestir microprojeções de perfuração de pele
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
SI1500390T1 (sl) * 2003-07-25 2006-02-28 Ferring Bv Farmacevtski dezmopresinski sestavek kot trdna dozirna oblika in postopek za njegovo pripravo
US6930932B2 (en) * 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
AU2004285484A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
EP1680057A4 (fr) * 2003-10-24 2007-10-31 Alza Corp Dispositif et procede d'amelioration de l'administration transdermique de medicament
CN100571643C (zh) * 2003-10-31 2009-12-23 阿尔扎公司 用于微凸起阵列的自驱动施加器
CA2545194C (fr) * 2003-11-10 2014-10-21 Seymour H. Fein Compositions pharmaceutiques comportant de la desmopressine faiblement dosee
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
PT1550439E (pt) 2003-12-29 2006-06-30 Ferring Bv Metodo para a preparacao de uma forma solida de dosagem de desmopressina
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
AU2004314416A1 (en) * 2004-01-09 2005-08-04 Alza Corporation Frequency assisted transdermal agent delivery method and system
PL1797109T3 (pl) * 2004-09-09 2016-11-30 Mieszaniny polipeptydów, kompozycje zawierające je i procesy ich wytwarzania oraz ich zastosowania
US7097776B2 (en) * 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) * 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) * 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
BRPI0610046A2 (pt) 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
CA2605554A1 (fr) 2005-04-22 2006-11-02 Wyeth Derives d'alcanamine de benzofuranyle et leurs utilisations comme agonistes 5-ht2c
BRPI0610027A2 (pt) 2005-04-22 2010-05-18 Wyeth Corp derivados de cromano e cromeno e usos dos mesmos
TW200719886A (en) 2005-04-22 2007-06-01 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
GT200600164A (es) 2005-04-22 2007-03-14 Derivados de dihidrobenzofuranos y usos de los mismos
JP2008538784A (ja) 2005-04-24 2008-11-06 ワイス 膀胱機能を調節するための方法
EP1893130A4 (fr) 2005-06-17 2015-08-26 Georgia Tech Res Inst Microstructures revetues et procede de fabrication de celles-ci
US20080195035A1 (en) 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
WO2007083323A2 (fr) 2006-01-23 2007-07-26 Panacea Biotec Limited. Administration orale de desmopressine et de ses sels
WO2007098945A2 (fr) 2006-03-02 2007-09-07 Ferring International Center S.A. Composition comprenant de la desmopressine
WO2007127976A2 (fr) 2006-05-01 2007-11-08 Georgia Tech Research Corporation Procédé de moulage basé sur des particules
US8399410B2 (en) * 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
DK3085381T3 (en) * 2008-05-21 2018-05-28 Ferring Bv ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY

Also Published As

Publication number Publication date
DK3225250T3 (da) 2019-11-04
JP6836618B2 (ja) 2021-03-03
JP2011520980A (ja) 2011-07-21
EP2296686B1 (fr) 2014-02-12
JP2018035198A (ja) 2018-03-08
HRP20161066T1 (hr) 2016-10-21
EP2712622B1 (fr) 2016-07-13
LT3085381T (lt) 2018-06-11
ES2756706T3 (es) 2020-04-27
PL2712622T3 (pl) 2017-01-31
JP2016196514A (ja) 2016-11-24
JP5767103B2 (ja) 2015-08-19
JP6258424B2 (ja) 2018-01-10
WO2009143356A1 (fr) 2009-11-26
LTPA2017001I1 (lt) 2017-02-10
TR201819189T4 (tr) 2019-01-21
HUE039013T2 (hu) 2018-12-28
EP2296686A1 (fr) 2011-03-23
PL2296686T3 (pl) 2014-07-31
NO2019021I1 (no) 2019-04-30
LT3225249T (lt) 2019-01-10
US20180250357A1 (en) 2018-09-06
EP3225250B1 (fr) 2019-08-21
ES2462465T5 (es) 2018-02-28
PT3225249T (pt) 2019-01-17
SI3225249T1 (sl) 2019-02-28
TR201807224T4 (tr) 2018-06-21
JP2015120761A (ja) 2015-07-02
ES2596435T3 (es) 2017-01-09
PT2712622T (pt) 2016-10-13
LT2712622T (lt) 2016-09-26
US20090291880A1 (en) 2009-11-26
HUE030409T2 (en) 2017-05-29
LUC00015I2 (fr) 2017-06-19
EP2296686B2 (fr) 2017-11-01
HRP20191854T1 (hr) 2019-12-27
PT3225250T (pt) 2019-10-15
EP3225249A1 (fr) 2017-10-04
EP2712622A1 (fr) 2014-04-02
NO3085381T3 (fr) 2018-09-15
HUE039013T4 (hu) 2019-08-28
JP2019123739A (ja) 2019-07-25
US9974826B2 (en) 2018-05-22
PL3225249T3 (pl) 2019-05-31
JP6506821B2 (ja) 2019-04-24
ES2677548T3 (es) 2018-08-03
SI2712622T1 (sl) 2016-10-28
DK2712622T3 (en) 2016-09-12
JP6001121B2 (ja) 2016-10-05
LUC00015I1 (fr) 2017-04-19
SI3225250T1 (sl) 2019-11-29
DK2296686T3 (da) 2014-05-12
HUS1900024I1 (hu) 2019-05-28
DK3085381T3 (en) 2018-05-28
SI3085381T1 (en) 2018-06-29
PL3225250T3 (pl) 2020-02-28
PL3085381T3 (pl) 2018-09-28
HUE046050T2 (hu) 2020-01-28
EP3225249B1 (fr) 2018-11-07
HUE041370T2 (hu) 2019-05-28
EP3085381B1 (fr) 2018-04-18
HRP20190114T1 (hr) 2019-03-08
PL2296686T5 (pl) 2018-06-29
HRP20180774T1 (hr) 2018-08-10
EP3225250A1 (fr) 2017-10-04
LTC2712622I2 (lt) 2020-02-10
ES2462465T3 (es) 2014-05-22
ES2710454T3 (es) 2019-04-25
EP3085381A1 (fr) 2016-10-26
DK3225249T3 (en) 2019-02-25
PT2296686E (pt) 2014-05-23
DK2296686T4 (en) 2018-01-02
PT3085381T (pt) 2018-05-18
LT3225250T (lt) 2019-11-11
CA2724653A1 (fr) 2009-11-26

Similar Documents

Publication Publication Date Title
BR112016019572A2 (fr)
BRPI0909040A2 (fr)
BRPI0917573A2 (fr)
BRPI0908549B8 (fr)
BRPI0918697A2 (fr)
BRPI0917525A2 (fr)
BRPI0920750A2 (fr)
BRPI0919470A2 (fr)
BRPI0922455A2 (fr)
BRPI0907698A2 (fr)
BRPI0917618A8 (fr)
BRPI0923734A2 (fr)
BRPI0912727A2 (fr)
BRPI0908285A2 (fr)
BRPI0910485A2 (fr)
BRPI0914750A2 (fr)
BRPI0922669A2 (fr)
BRPI0908120A2 (fr)
BRPI0912462A2 (fr)
BRPI0915616A2 (fr)
BRPI0904541A8 (fr)
BRPI0919811A2 (fr)
BRPI0920914A2 (fr)
BRPI0922550A2 (fr)
BRPI0916284A2 (fr)